PS PS128
LIVE

Serial Number

79343508

Owner

Bened Biomedical Co., Ltd.

Attorney

Yue (Robert) Xu

Filing Date

Jan 18, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PS PS128 Trademark

Serial Number: 79343508 • Registration: 7383171

PS PS128 is a trademark filed by Bened Biomedical Co., Ltd. on January 18, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods). The application is currently registered and active.

Owner Contact Info

Bened Biomedical Co., Ltd. (2 trademarks)

8F., No. 508, Sec. 7,

Entity Type: 98

Trademark Details

Filing Date

January 18, 2022

Registration Date

May 14, 2024

Published for Opposition

February 27, 2024

Goods & Services

Yogurt made in whole or substantial part of Lactobacillus plantarum PS128; whey made in whole or substantial part of Lactobacillus plantarum PS128; milk products made in whole or substantial part of Lactobacillus plantarum PS128 namely, milk-based nutritional supplement drinks; milk ferments for culinary purposes made in whole or substantial part of Lactobacillus plantarum PS128; powdered milk made in whole or substantial part of Lactobacillus plantarum PS128; beverages having a milk base made in whole or substantial part of Lactobacillus plantarum PS128; yogurt drinks made in whole or substantial part of Lactobacillus plantarum PS128; milk solids made in whole or substantial part of Lactobacillus plantarum PS128

Pharmaceutical agents affecting peripheral nervous system made in whole or substantial part of Lactobacillus plantarum PS128; pharmaceutical preparations acting on the central nervous system made in whole or substantial part of Lactobacillus plantarum PS128; medicated candies made in whole or substantial part of Lactobacillus plantarum PS128; dietetic foods adapted for medical use made in whole or substantial part of Lactobacillus plantarum PS128; biological preparations for veterinary purposes made in whole or substantial part of Lactobacillus plantarum PS128 for the treatment of separation anxiety, aggression, compulsive disorder, excessive barking, yowl and stabilize emotional status; Preparations of microorganisms for medical or veterinary use made in whole or substantial part of Lactobacillus plantarum PS128 for the treatment of autism spectrum disorder, Parkinson's disease, Alzheimer's disease, depressive disorder, Tourette syndrome, visceral hypersensitivity, constipation, insomnia, stress, separation anxiety, aggression, compulsive disorder, excessive barking, yowl and stabilize emotional status; nutraceutical preparations for therapeutic or medical purposes made in whole or substantial part of Lactobacillus plantarum PS128 for the treatment of autism spectrum disorder, Parkinson's disease, Alzheimer's disease, depressive disorder, Tourette syndrome, visceral hypersensitivity, constipation, insomnia, and stress; milk ferments for pharmaceutical purposes made in whole or substantial part of Lactobacillus plantarum PS128; biological preparations for medical purposes made in whole or substantial part of Lactobacillus plantarum PS128 for the treatment of autism spectrum disorder, Parkinson's disease, Alzheimer's disease, depressive disorder, Tourette syndrome, visceral hypersensitivity, constipation, insomnia, and stress; powdered whey proteins being nutritional supplements made in whole or substantial part of Lactobacillus plantarum PS128

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 7, 2025 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 30, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 7, 2024 FICS
FINAL DISPOSITION PROCESSED
Nov 7, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 14, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 14, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
May 14, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 4, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 27, 2024 PUBO
NOTIFICATION PROCESSED BY IB
Feb 26, 2024 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 7, 2024 OPNS
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 7, 2024 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 7, 2024 NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 7, 2024 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 7, 2024 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 23, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 19, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 18, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 18, 2024 ERFR
ASSIGNED TO EXAMINER
Jan 12, 2024 DOCK
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 25, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 6, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 6, 2023 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 21, 2023 GNFN
FINAL REFUSAL E-MAILED
Jul 21, 2023 GNFR
FINAL REFUSAL WRITTEN
Jul 21, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 6, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 6, 2023 TROA
REFUSAL PROCESSED BY IB
Feb 7, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 18, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jan 17, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 4, 2022 RFCR
NON-FINAL ACTION WRITTEN
Nov 3, 2022 CNRT
ASSIGNED TO EXAMINER
Oct 27, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 5, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 1, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 30, 2022 REPR